Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis
- PMID: 29653861
- DOI: 10.1016/j.ophtha.2018.03.004
Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis
Comment in
-
Bindehaut- und Hornhauterkrankungen.Ophthalmologe. 2019 Nov;116(11):1006-1007. doi: 10.1007/s00347-019-00958-w. Ophthalmologe. 2019. PMID: 31696286 German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical